<VariationArchive VariationID="871891" VariationName="NM_145239.3(PRRT2):c.971dup (p.Val325fs)" VariationType="Duplication" Accession="VCV000871891" Version="31" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-29" DateCreated="2020-05-12" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="860254" VariationID="871891">
      <GeneList>
        <Gene Symbol="MVP-DT" FullName="MVP divergent transcript" GeneID="112268170" HGNC_ID="HGNC:56029" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29808644" stop="29820367" display_start="29808644" display_stop="29820367" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="PRRT2" FullName="proline rich transmembrane protein 2" GeneID="112476" HGNC_ID="HGNC:30500" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29812193" stop="29815881" display_start="29812193" display_stop="29815881" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29823408" stop="29827201" display_start="29823408" display_stop="29827201" Strand="+" />
          </Location>
          <OMIM>614386</OMIM>
          <Haploinsufficiency last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-12-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PRRT2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_145239.3(PRRT2):c.971dup (p.Val325fs)</Name>
      <CanonicalSPDI>NC_000016.10:29814418:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="29814418" stop="29814419" display_start="29814418" display_stop="29814419" variantLength="1" positionVCF="29814418" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="29825739" stop="29825740" display_start="29825739" display_stop="29825740" variantLength="1" referenceAllele="T" alternateAllele="TG" positionVCF="29825739" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>V325fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.29814424dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.29814424dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.29825745dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.29825745dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032039.1" sequenceAccession="NG_032039" sequenceVersion="1" change="g.7337dup">
            <Expression>NG_032039.1:g.7337dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256442.2" sequenceAccession="NM_001256442" sequenceVersion="2" change="c.971dup">
            <Expression>NM_001256442.2:c.971dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243371.1" sequenceAccession="NP_001243371" sequenceVersion="1" change="p.Val325fs">
            <Expression>NP_001243371.1:p.Val325fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256443.2" sequenceAccession="NM_001256443" sequenceVersion="2" change="c.*470dup">
            <Expression>NM_001256443.2:c.*470dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_145239.3" sequenceAccession="NM_145239" sequenceVersion="3" change="c.971dup" MANESelect="true">
            <Expression>NM_145239.3:c.971dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_660282.2" sequenceAccession="NP_660282" sequenceVersion="2" change="p.Val325fs">
            <Expression>NP_660282.2:p.Val325fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="NP_660282.2" sequenceAccession="NP_660282" sequenceVersion="2" change="p.(Val325SerfsTer16)">
            <Expression>NP_660282.2:p.(Val325SerfsTer16)</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256442.1" sequenceAccession="NM_001256442" sequenceVersion="1" change="c.971dupG">
            <Expression>NM_001256442.1:c.971dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="796052941" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_145239.3(PRRT2):c.971dup (p.Val325fs) AND not provided" Accession="RCV001092090" Version="18">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.971dup (p.Val325fs) AND Episodic kinesigenic dyskinesia" Accession="RCV001208461" Version="6">
        <ClassifiedConditionList TraitSetID="44946">
          <ClassifiedCondition DB="MedGen" ID="C1868682">Episodic kinesigenic dyskinesia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.971dup (p.Val325fs) AND Seizures, benign familial infantile, 2" Accession="RCV001644913" Version="3">
        <ClassifiedConditionList TraitSetID="8089">
          <ClassifiedCondition DB="MedGen" ID="C1853995">Seizures, benign familial infantile, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-03-06" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.971dup (p.Val325fs) AND Episodic kinesigenic dyskinesia 1" Accession="RCV002249678" Version="2">
        <ClassifiedConditionList TraitSetID="6917">
          <ClassifiedCondition DB="MedGen" ID="C4552000">Episodic kinesigenic dyskinesia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_145239.3(PRRT2):c.971dup (p.Val325fs) AND PRRT2-related disorder" Accession="RCV004545049" Version="1">
        <ClassifiedConditionList TraitSetID="79405">
          <ClassifiedCondition>PRRT2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-23" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2020-05-12" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2131349</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23496026</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24609974</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24886244</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32392383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34298581</ID>
        </Citation>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="44946" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36813" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic dyskinesia</ElementValue>
                <XRef ID="98809" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial paroxysmal dystonia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EKD</ElementValue>
                <XRef ID="MONDO:0044202" DB="MONDO" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C1868682" DB="MedGen" />
              <XRef ID="MONDO:0044202" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8089" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1006" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial infantile, 2</ElementValue>
                <XRef ID="MONDO:0011593" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFIC2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BFIS2</ElementValue>
                <XRef Type="MIM" ID="605751" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16504" />
                <XRef ID="16504" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="306" DB="Orphanet" />
              <XRef ID="C1853995" DB="MedGen" />
              <XRef ID="MONDO:0011593" DB="MONDO" />
              <XRef Type="MIM" ID="605751" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6917" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1187" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial Paroxysmal Kinesigenic Dyskinesia</ElementValue>
                <XRef ID="NBK1460" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic kinesigenic dyskinesia 1</ElementValue>
                <XRef ID="MONDO:0007494" DB="MONDO" />
                <XRef ID="MONDO:0100352" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PxMD-PRRT2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 10</ElementValue>
                <XRef ID="Dystonia+10/2407" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal kinesigenic choreoathetosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PKD</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DYT10</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKC</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EKD1</ElementValue>
                <XRef Type="MIM" ID="128200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8721" />
                <XRef ID="8721" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PRRT2-associated paroxysmal movement disorders (PRRT2-PxMD) include paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC), and hemiplegic migraine (HM). In addition, PRRT2 pathogenic variants have been identified in other childhood-onset movement disorders and different types of seizures, suggesting that the understanding of the spectrum of PRRT2-PxMD is still evolving. The paroxysmal attacks in PKD are characterized by dystonia, choreoathetosis, and less commonly ballismus. The seizures of BFIE are usually focal with or without generalization. Thirty percent of PRRT2-associated PKD is associated with BFIE and is referred to as PKD/IC.</Attribute>
                <XRef ID="NBK475803" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334453</ID>
                <ID Source="BookShelf">NBK475803</ID>
              </Citation>
              <XRef ID="98809" DB="Orphanet" />
              <XRef ID="C4552000" DB="MedGen" />
              <XRef ID="MONDO:0100352" DB="MONDO" />
              <XRef Type="MIM" ID="128200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79405" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">PRRT2-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2470050" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="102163|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001248451" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="TG" referenceAllele="T" start="29825739" stop="29825739" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3417729" SubmissionDate="2021-06-16" DateLastUpdated="2021-09-19" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="NM_145239.2:c.971dup|OMIM:605751" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001737519" DateUpdated="2021-09-19" DateCreated="2021-09-19" Type="SCV" Version="1" SubmitterName="The Laboratory of Genetics and Metabolism, Hunan Children’s Hospital" OrgID="507019" OrganizationCategory="laboratory" OrgAbbreviation="LOGM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">34298581</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Han Chinese</Ethnicity>
              <GeographicOrigin>China</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_660282.2:p.(Val325SerfsTer16)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_145239.2:c.971dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605751" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">34298581</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34298581</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB9827004</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4933807" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000016.10:g.29814418_29814419insG|OMIM:128200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002518924" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.10:g.29814418_29814419insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2714624" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="6977854|MedGen:C1868682" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001379851" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32392383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">2131349</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23496026</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24609974</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24886244</ID>
          </Citation>
          <Comment>This variant is also known as c.971_972insG. This premature translational stop signal has been observed in individual(s) with paroxysmal kinesigenic dyskinesia (PMID: 32392383). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Val325Serfs*16) in the PRRT2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 16 amino acid(s) of the PRRT2 protein. ClinVar contains an entry for this variant (Variation ID: 871891). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PRRT2 protein in which other variant(s) (p.Ile327Met) have been determined to be pathogenic (PMID: 2131349, 23496026, 24609974, 24886244). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.29825739_29825740insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868682" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8882122" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="40175264|PRRT2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004800479" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PRRT2 c.971dupG variant is predicted to result in a frameshift and premature protein termination (p.Val325Serfs*15). This variant has been reported in an individual with paroxysmal kinesigenic dyskinesia (Huang et al. 2020. PubMed ID: 32392383) and it has also been reported in an individual with infantile seizures (Table 2, Liu et al. 2021. PubMed ID: 34298581). This variant is reported in 0.00091% of alleles in individuals of European (non-Finnish) descent in gnomAD. Frameshift variants in PRRT2 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRRT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001256442.1:c.971dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PRRT2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4933807" TraitType="Disease" MappingType="XRef" MappingValue="128200" MappingRef="OMIM">
        <MedGen CUI="C4552000" Name="Episodic kinesigenic dyskinesia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3417729" TraitType="Disease" MappingType="XRef" MappingValue="605751" MappingRef="OMIM">
        <MedGen CUI="C1853995" Name="Seizures, benign familial infantile, 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2714624" TraitType="Disease" MappingType="XRef" MappingValue="C1868682" MappingRef="MedGen">
        <MedGen CUI="C1868682" Name="Episodic kinesigenic dyskinesia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8882122" TraitType="Disease" MappingType="Name" MappingValue="PRRT2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="PRRT2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2470050" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

